THE WHAT? Bloomberg reports that buyout firm TA Associates is considering the divestment of its Laboratoires Vivacy brand.

THE DETAILS A potential deal could place Vivacy in the billion-dollar brand club, with the valuation pegged at €1 billion, according to Bloomberg quoting anonymous sources ‘familiar with the matter’. TA Associates is said to be working with Rothschild and BNP Paribas on a potential deal.

THE WHY? Vivacy, TA Associates, Rothschild and BNP Paribas all declined to comment when contacted by Bloomberg. TA Associates purchased a majority stake in the injectables brand back in 2019 and rumblings of a potential sale have been heard since the start of 2022, although rumors have yet to result in a concrete deal.